Showing results (421-430 of 2,190) with videos related to
Sort By:
Pageof 219
Spine|April 9, 2010
Craniocervical fixation with occipital condyle screws: biomechanical analysis of a novel techniqueJuan S Uribe, Edwin Ramos, A Samy Youssef, et al.Health Economics|June 22, 2000
Evidence-based medicine and health economics: a case study of end stage renal diseaseL Vale, C Donaldson, C Daly, et al.Analytical Methods : Advancing Methods and Applications|October 13, 2025
Development of portable equipment based on computer vision and colorimetric assays to measure the biodiesel content in BX dieselRafael S Xavier, Thiago S Dias, Débora F de Andrade, et al.Journal of Trace Elements in Medicine and Biology : Organ of the Society for Minerals and Trace Elements (GMS)|February 5, 2022
Association between zinc and body composition: An integrative reviewThais A Cunha, Karina M Vermeulen-Serpa, Evellyn C Grilo, et al.The Cochrane Database of Systematic Reviews|June 19, 2001
Double bag or Y-set versus standard transfer systems for continuous ambulatory peritoneal dialysis in end-stage renal diseaseC Daly, M Campbell, J Cody, et al.International Urogynecology Journal|May 27, 2019
Effect of the platelet-rich plasma covering of polypropylene mesh on oxidative stress, inflammation, and adhesionsVanessa Belebecha, Rúbia Casagrande, Mariana R Urbano, et al.European Journal of Pharmacology|January 14, 2000
Involvement of resident macrophages and mast cells in the writhing nociceptive response induced by zymosan and acetic acid in miceR A Ribeiro, M L Vale, S M Thomazzi, et al.The Cochrane Database of Systematic Reviews|November 1, 2001
Recombinant human erythropoietin for chronic renal failure anaemia in pre-dialysis patientsJ Cody, C Daly, M Campbell, et al.Epilepsy & Behavior : E&B|August 18, 2015
Laser ablation therapy: An alternative treatment for medically resistant mesial temporal lobe epilepsy after age 50Hena Waseem, Katie E Osborn, Mike R Schoenberg, et al.Clinical Lung Cancer|December 31, 2014
Should Tyrosine Kinase Inhibitors Be Considered for Advanced Non-Small-Cell Lung Cancer Patients With Wild Type EGFR? Two Systematic Reviews and Meta-Analyses of Randomized TrialsClaire L Vale, Sarah Burdett, David J Fisher, et al.Pageof 219